French Pharmaceuticals & Biotech Buy the Dip

Results

2 new

Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.

2 companies

DBV Technologies

Market Cap: €732.1m

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

DBV

€2.47

-12.7%

58.8%

Advicenne

Market Cap: €23.6m

A specialty pharmaceutical company, develops, commercializes, and safe treatments for rare renal diseases in France and internationally.

ALDVI

€1.62

-10.0%

37.1%